Marshall & Sullivan Inc Becton Dickinson & CO Transaction History

Marshall & Sullivan Inc

  • $198 Million
  • Q3 2024

A detailed history of Marshall & Sullivan Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marshall & Sullivan Inc holds 18,763 shares of BDX stock, worth $4.22 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares
18,763
Previous 18,856 0.49%
Holding current value
$4.22 Million
Previous $4.41 Million 2.66%
% of portfolio
2.28%
Previous 2.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
SELL
$221.47 - $242.41 $20,596 - $22,544
-93 Reduced 0.49%
18,763 $4.52 Million
Q2 2024

Jul 12, 2024
SELL
$225.07 - $246.17 $41,412 - $45,295
-184 Reduced 0.97%
18,856 $4.41 Million
Q1 2024

Apr 10, 2024
BUY
$233.45 - $247.73 $10,738 - $11,395
46 Added 0.24%
19,040 $4.71 Million
Q4 2023

Jan 11, 2024
SELL
$232.24 - $267.23 $7,431 - $8,551
-32 Reduced 0.17%
18,994 $4.63 Million
Q3 2023

Oct 06, 2023
SELL
$254.9 - $283.59 $52,509 - $58,419
-206 Reduced 1.07%
19,026 $4.92 Million
Q2 2023

Jul 12, 2023
BUY
$238.39 - $265.32 $67,702 - $75,350
284 Added 1.5%
19,232 $5.08 Million
Q1 2023

Apr 10, 2023
BUY
$229.71 - $259.35 $68,683 - $77,545
299 Added 1.6%
18,948 $4.69 Million
Q4 2022

Jan 18, 2023
SELL
$218.29 - $256.91 $80,112 - $94,285
-367 Reduced 1.93%
18,649 $0
Q3 2022

Oct 28, 2022
BUY
$51.03 - $264.23 $3,061 - $15,853
60 Added 0.32%
19,016 $4.24 Million
Q2 2022

Jul 06, 2022
BUY
$234.74 - $275.42 $27,699 - $32,499
118 Added 0.63%
18,956 $4.67 Million
Q1 2022

May 02, 2022
SELL
$243.64 - $270.48 $184,191 - $204,482
-756 Reduced 3.86%
18,838 $5.01 Million
Q4 2021

Jan 24, 2022
BUY
$230.08 - $250.94 $53,608 - $58,469
233 Added 1.2%
19,594 $4.93 Million
Q3 2021

Oct 19, 2021
BUY
$232.72 - $256.47 $220,618 - $243,133
948 Added 5.15%
19,361 $4.76 Million
Q2 2021

Aug 09, 2021
BUY
$232.65 - $254.58 $65,142 - $71,282
280 Added 1.54%
18,413 $4.48 Million
Q1 2021

May 04, 2021
BUY
$232.09 - $256.88 $3.18 Million - $3.52 Million
13,710 Added 309.97%
18,133 $4.41 Million
Q4 2020

Jan 29, 2021
SELL
$221.92 - $245.94 $2.89 Million - $3.2 Million
-13,004 Reduced 74.62%
4,423 $17.7 Million
Q3 2020

Nov 02, 2020
BUY
$215.77 - $276.76 $40,348 - $51,754
187 Added 1.08%
17,427 $4.06 Million
Q2 2020

Jul 14, 2020
SELL
$219.9 - $263.41 $16,052 - $19,228
-73 Reduced 0.42%
17,240 $4.13 Million
Q1 2020

May 06, 2020
SELL
$195.69 - $279.01 $245,982 - $350,715
-1,257 Reduced 6.77%
17,313 $3.98 Million
Q4 2019

Jan 14, 2020
SELL
$236.45 - $266.82 $31,211 - $35,220
-132 Reduced 0.71%
18,570 $5.05 Million
Q3 2019

Oct 11, 2019
SELL
$230.58 - $256.08 $2,075 - $2,304
-9 Reduced 0.05%
18,702 $4.73 Million
Q2 2019

Aug 05, 2019
SELL
$217.4 - $246.08 $33,044 - $37,404
-152 Reduced 0.81%
18,711 $4.72 Million
Q1 2019

May 08, 2019
BUY
$206.05 - $248.17 $43,270 - $52,115
210 Added 1.13%
18,863 $4.71 Million
Q4 2018

Jan 28, 2019
SELL
$204.73 - $257.93 $140,035 - $176,424
-684 Reduced 3.54%
18,653 $4.2 Million
Q3 2018

Oct 29, 2018
BUY
$233.07 - $256.0 $15,382 - $16,896
66 Added 0.34%
19,337 $5.05 Million
Q2 2018

Jul 31, 2018
BUY
$208.1 - $233.85 $50,984 - $57,293
245 Added 1.29%
19,271 $0
Q1 2018

Apr 30, 2018
SELL
$205.46 - $240.27 $235,457 - $275,349
-1,146 Reduced 5.68%
19,026 $4.12 Million
Q4 2017

Feb 09, 2018
SELL
$189.0 - $222.64 $62,937 - $74,139
-333 Reduced 1.62%
20,172 $4.32 Million
Q3 2017

Nov 09, 2017
SELL
$186.89 - $198.9 $15,138 - $16,110
-81 Reduced 0.39%
20,505 $4.28 Million
Q2 2017

Aug 09, 2017
BUY
N/A
20,586
20,586 $4.02 Million

Others Institutions Holding BDX

# of Institutions
1,735
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Marshall & Sullivan Inc Portfolio

Follow Marshall & Sullivan Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall & Sullivan Inc , based on Form 13F filings with the SEC.

News

Stay updated on Marshall & Sullivan Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email